ACHFF
Price
$0.69
Change
+$0.01 (+1.47%)
Updated
Oct 24 closing price
Capitalization
46.31M
Intraday Buy/Sell Signals
AGTX
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 24 closing price
Capitalization
2M
Intraday Buy/Sell Signals
Interact to see
Advertisement

ACHFF vs AGTX

Header iconACHFF vs AGTX Comparison
Open Charts ACHFF vs AGTXBanner chart's image
Arch Biopartners
Price$0.69
Change+$0.01 (+1.47%)
Volume$66K
Capitalization46.31M
Agentix
Price$0.05
Change-$0.00 (-0.00%)
Volume$8.5K
Capitalization2M
ACHFF vs AGTX Comparison Chart in %
ACHFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHFF vs. AGTX commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHFF is a Hold and AGTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (ACHFF: $0.69 vs. AGTX: $0.05)
Brand notoriety: ACHFF and AGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHFF: 166% vs. AGTX: 28%
Market capitalization -- ACHFF: $46.31M vs. AGTX: $2M
ACHFF [@Biotechnology] is valued at $46.31M. AGTX’s [@Biotechnology] market capitalization is $2M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHFF’s FA Score shows that 0 FA rating(s) are green whileAGTX’s FA Score has 1 green FA rating(s).

  • ACHFF’s FA Score: 0 green, 5 red.
  • AGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, AGTX is a better buy in the long-term than ACHFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHFF’s TA Score shows that 5 TA indicator(s) are bullish while AGTX’s TA Score has 3 bullish TA indicator(s).

  • ACHFF’s TA Score: 5 bullish, 3 bearish.
  • AGTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACHFF is a better buy in the short-term than AGTX.

Price Growth

ACHFF (@Biotechnology) experienced а +1.45% price change this week, while AGTX (@Biotechnology) price change was +1.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHFF($46.3M) has a higher market cap than AGTX($2M). ACHFF YTD gains are higher at: -48.524 vs. AGTX (-71.827). AGTX has higher annual earnings (EBITDA): -545.9K vs. ACHFF (-2.07M). ACHFF has more cash in the bank: 167K vs. AGTX (4.41K). AGTX has less debt than ACHFF: AGTX (343K) vs ACHFF (2.44M). ACHFF (0) and AGTX (0) have equivalent revenues.
ACHFFAGTXACHFF / AGTX
Capitalization46.3M2M2,312%
EBITDA-2.07M-545.9K380%
Gain YTD-48.524-71.82768%
P/E RatioN/AN/A-
Revenue00-
Total Cash167K4.41K3,785%
Total Debt2.44M343K711%
FUNDAMENTALS RATINGS
ACHFF vs AGTX: Fundamental Ratings
ACHFF
AGTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9538
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
4175

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGTX's Valuation (4) in the null industry is significantly better than the same rating for ACHFF (94). This means that AGTX’s stock grew significantly faster than ACHFF’s over the last 12 months.

AGTX's Profit vs Risk Rating (100) in the null industry is in the same range as ACHFF (100). This means that AGTX’s stock grew similarly to ACHFF’s over the last 12 months.

AGTX's SMR Rating (100) in the null industry is in the same range as ACHFF (100). This means that AGTX’s stock grew similarly to ACHFF’s over the last 12 months.

AGTX's Price Growth Rating (38) in the null industry is somewhat better than the same rating for ACHFF (95). This means that AGTX’s stock grew somewhat faster than ACHFF’s over the last 12 months.

ACHFF's P/E Growth Rating (98) in the null industry is in the same range as AGTX (100). This means that ACHFF’s stock grew similarly to AGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHFFAGTX
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
59%
Momentum
ODDS (%)
Bearish Trend 5 days ago
73%
Bullish Trend 3 days ago
63%
MACD
ODDS (%)
Bullish Trend 3 days ago
56%
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
78%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
52%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ACHFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VLERF4.850.10
+2.14%
Valeura Energy Inc.
BEWFF0.54N/A
N/A
BeWhere Holdings Inc.
ODERF11.60N/A
N/A
Odakyu Electric Railway Co., Ltd.
NEVIF0.06N/A
N/A
Nevis Brands Inc.
KKPNF4.78-0.19
-3.75%
Royal KPN NV

ACHFF and

Correlation & Price change

A.I.dvisor tells us that ACHFF and LABFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHFF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHFF
1D Price
Change %
ACHFF100%
+2.10%
LABFF - ACHFF
21%
Poorly correlated
N/A
ARGNF - ACHFF
11%
Poorly correlated
N/A
AGTX - ACHFF
4%
Poorly correlated
+0.84%
ADCT - ACHFF
4%
Poorly correlated
+0.49%
INBX - ACHFF
3%
Poorly correlated
+102.01%
More

AGTX and

Correlation & Price change

A.I.dvisor tells us that AGTX and RLAY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGTX and RLAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGTX
1D Price
Change %
AGTX100%
+0.84%
RLAY - AGTX
32%
Poorly correlated
+1.48%
RVMD - AGTX
28%
Poorly correlated
+1.95%
SKYE - AGTX
23%
Poorly correlated
+6.21%
ALGS - AGTX
23%
Poorly correlated
+2.05%
BCYC - AGTX
22%
Poorly correlated
+0.90%
More